Press Releases

Date Title
Sep 29, 2022 Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum
Sep 29, 2022 Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health
Sep 26, 2022 Illumina Genomics Forum Sold Out, Announces Opportunity to View Innovation Roadmap Session via Livestream
Sep 19, 2022 Illumina to Host Upcoming Investor Day
Sep 19, 2022 Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient Care
Sep 14, 2022 Illumina Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women's Health, and Sustainable Agriculture Applications
Sep 12, 2022 Illumina Genomics Forum to Convene Leading Visionaries to Explore Architecting Health's Radically New Infrastructure
Sep 8, 2022 Illumina Announces Opportunity to View Live Webcast of Illumina Genomics Forum Innovation Roadmap Session Followed by Investor Conference Call
Sep 7, 2022 Illumina Genomics Forum to Feature Diverse Lineup of Visionary Global Leaders
Sep 6, 2022 Illumina Intends to Appeal European Commission's Decision in GRAIL Deal
Sep 5, 2022 Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients
Sep 1, 2022 Administrative Law Judge Rules in Favor of Illumina in FTC Challenge of GRAIL Deal
Aug 30, 2022 Illumina Deepens Commitment to Customers in China with New Manufacturing Site
Aug 29, 2022 Illumina Genomics Forum to Feature Tennis Legend Chris Evert on the Role Genomics Played in her Cancer Fight
Aug 22, 2022 Illumina Genomics Forum to Feature 23andMe Co-founder and CEO Anne Wojcicki
Aug 16, 2022 Minderoo Foundation and Illumina Commit $40M AUD to Apply Advanced Genomics to Marine Conservation
Aug 15, 2022 Illumina Genomics Forum to Feature American Cancer Society CEO Karen Knudsen on the Future of Cancer Genomics
Aug 11, 2022 Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022
Aug 8, 2022 Illumina Genomics Forum to Feature Bill Gates and Distinguished Health Leaders Addressing Need for Global Access to Genomics
Jul 27, 2022 Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities
Jul 18, 2022 Illumina Announces Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President Barack Obama
Jul 14, 2022 Illumina to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022
Jul 14, 2022 Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
Jun 28, 2022 Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
Jun 22, 2022 Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
Jun 9, 2022 Joydeep Goswami Appointed Interim CFO; Sam Samad To Depart Illumina
Jun 7, 2022 Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions
Jun 2, 2022 Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO
May 24, 2022 Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy
May 18, 2022 Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
May 5, 2022 Illumina Reports Financial Results for First Quarter of Fiscal Year 2022
May 5, 2022 Illumina and Deerfield Management partner to accelerate drug development
Apr 28, 2022 Illumina To Webcast Upcoming Investor Conference
Apr 25, 2022 Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
Apr 14, 2022 Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
Apr 12, 2022 Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution Center
Apr 11, 2022 John Frank Joins Illumina as Chief Public Affairs Officer
Apr 7, 2022 Illumina Releases Annual Corporate Social Responsibility Report
Mar 16, 2022 Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
Mar 15, 2022 Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
Mar 14, 2022 Illumina Welcomes Carissa Rollins as Chief Information Officer
Feb 21, 2022 Illumina To Webcast Upcoming Investor Conference
Feb 10, 2022 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021
Feb 3, 2022 Illumina To Webcast Upcoming Investor Conferences
Feb 3, 2022 Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer
Jan 24, 2022 Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia
Jan 20, 2022 Illumina to Announce Fourth Quarter & Full Year 2021 Financial Results on Thursday, February 10, 2022
Jan 10, 2022 Illumina collaborates with Nashville Biosciences to accelerate medicines development
Jan 10, 2022 Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care
Jan 10, 2022 Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
Jan 10, 2022 Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference
Jan 5, 2022 Illumina Enters Co-Development Partnership with SomaLogic